ArticleBMC plant biology2025
Developmental and quantitative expression profile of the six pollen allergens of mugwort (Artemisia vulgaris L.).
Article in BMC plant biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundArtemisia vulgaris L. (Asteraceae family), a wind-pollinated perennial weed, is a significant source of allergenic pollen, responsible for respiratory allergies in late summer. Six allergenic proteins-Art v 1, Art v 2, Art v 3, Art v 4, Art v 5, and Art v 6-have been identified in A. vulgaris pollen. However, knowledge regarding significant scientific questions, such as where, when, and in what quantities these proteins are expressed, remains limited.
resultsThis study fills these gaps by determining the expression profiles of all six genes encoding allergenic proteins in mugwort pollen. The real-time PCR method was used to analyze the level of allergen expression at three stages of pollen development: microsporocytes before meiosis (stage I), tetrads after meiosis (stage II), and enclosed mature pollen (stage IIIa), as well as isolated mature pollen grains (stage IIIb). The results showed that the expression levels of the most immunogenic allergens, Art v 1 and Art v 3, are extremely high at stage IIIa but very low at stage IIIb, suggesting their production occurs in mature inflorescence tissues. The expression levels of these two major allergens are significantly higher than those of other minor allergens in Artemisia pollen. Art v 2 is expressed in both pollen grains and anther tissues, whereas Art v 5 and Art v 6 are transcribed only in mature pollen, with no noticeable expression in earlier stages of pollen development. Art v 4 expression begins at the tetrad stage and reaches its highest levels in mature pollen grains, where it surpasses the expression level of all other allergens.
conclusionsOur study provides new insights into allergen expression in A. vulgaris pollen, highlighting significant quantitative and developmental differences. These findings may help explain why some proteins are more likely to cause pollen allergies than others.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.